CD163 and primary central nervous system lymphoma: In another study of independent PCNSL cohort (n = 47), contrary to their conclusion, increased numbers of CD68+ TAMs were significantly associated with progression-free survival, and a trend was observed for the increased CD163+ TAMs and shorter survival.